Description
Jointly provided by Partners for Advancing Clinical Education (PACE) and Ig National Society, Inc.
Original Release Date: March 31, 2025
Expiration Date: March 31, 2028
Speakers:
Leslie Myers, PharmD, IgCP®
Deandrea King, MD
Ken Paris, MD, MPH
Amy Clarke, DNP, RN, IgCN®
Christie Fisher, MSN, MBA, RN, CRNI, IgCN®
Amy Ehlers, BS, PharmD, CSP, IgCP®
Joe DiStefano, RPh, IgCP®, CSP
Continuing Education: Physician 5.75 AMA PRA Category 1 Credit(s)™ | Nursing 5.75 contact hour | Pharmacy 5.75 contact hour
Recertification: 5.75 IgCN® / IgCP® Recertification Units
Target Audience
This activity is intended for physicians, nurses, pharmacists, and other healthcare professionals who care for patients in need of immunoglobulin therapy and specialty biologics.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Describe the various types of immunoglobulin products available, their specific indications for use in different disease states, and the mechanisms of action involved
- Discuss the specific clinical indications and rationale for Ig therapy in primary immunodeficiencies, neuromuscular disorders
- Apply safe administration techniques for Ig therapy, including proper infusion techniques and monitoring protocols
- Implement comprehensive risk assessments before initiating Ig therapy, including identification and management of potential risks and complications in diverse patient populations
- Demonstrate Improved interprofessional collaboration and communication among healthcare team members to enhance the delivery of Ig therapy
